Welcome to LookChem.com Sign In|Join Free

CAS

  • or

91681-56-0

Post Buying Request

91681-56-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91681-56-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91681-56-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,6,8 and 1 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 91681-56:
(7*9)+(6*1)+(5*6)+(4*8)+(3*1)+(2*5)+(1*6)=150
150 % 10 = 0
So 91681-56-0 is a valid CAS Registry Number.
InChI:InChI=1/C26H50O4/c1-3-5-7-9-11-13-15-17-19-21-24(23-25(27)28)30-26(29)22-20-18-16-14-12-10-8-6-4-2/h24H,3-23H2,1-2H3,(H,27,28)/t24-/m1/s1

91681-56-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-oxo-3-undecylpentadecanoic acid

1.2 Other means of identification

Product number -
Other names 3-(decanoyloxy)tetradecanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91681-56-0 SDS

91681-56-0Downstream Products

91681-56-0Relevant articles and documents

BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPY

-

, (2021/02/12)

The invention relates to a bifunctional compound that is, on one side, an agonist of the TLR4 and, on the other side, an important inhibitor of the PSMA. Said compound is useful in immunotherapy for the treatment and/or prevention of prostate cancer. Therefore, the invention also relates to the use of the compound and to the pharmaceutical composition comprising it.

One-Pot Protection Strategy of Glucosamine to Assemble Building Blocks of Chitosan and Lipid A

Chen, Jyun-Siao,Huang, Po-Hsun,Lin, Yi-Jyun,Liu, Jen-Wei,Liu, Yu-Hao,Luo, Shun-Yuan,Pantawane, Amit Ravindra,Sankar, Arumugam,Wu, Hsin-Ru

, (2020/08/21)

This investigation describes a one-pot reaction to prepare a series of building blocks for glycosylation reactions, such as 3-alcohol glucosamines, fully protected glucosamines, O-4 and O-6 alcohol glucosamines. These reactions readily produce not only gl

Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors

-

, (2008/06/13)

Aminoalkyl glucosaminide phosphate (AGP) compounds that are adjuvants and immunoeffectors are described and claimed. The compounds have a 2-deoxy-2-amino glucose in glycosidic linkage with an aminoalkyl (aglycon) group. Compounds are phosphorylated at the 4 or 6 carbon on the glucosaminide ring and comprise three 3-alkanoyloxyalkanoyl residues. The compounds augment antibody production in immunized animals as well as stimulate cytokine production and activate macrophages. Compositions and methods for using the compounds as adjuvants and immunoeffectors are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91681-56-0